Docality.com Logo
 
Dr. Akiko  Saberi  Md image

Dr. Akiko Saberi Md

2101 Elm St N Vamc
Fargo ND 58102
701 323-3241
Medical School: Other - Unknown
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: No
Participates In EHR: No
License #: 4635
NPI: 1588604326
Taxonomy Codes:
207ZP0102X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

None Found

Publications

Late adrenal metastasis in operable non-small-cell lung carcinoma. - American journal of clinical oncology
Treatment of early-stage (I, II, and some IIIA) non-small-cell lung cancer (NSCLC) is curative resection. Simultaneous isolated adrenal metastasis represents a dilemma. Although many studies addressing the management of adrenal metastasis diagnosed simultaneously with NSCLC have been published, only very few reports of late adrenal metastasis can be found in the literature. Our purpose is to discuss the management of solitary late (metachronous) adrenal metastasis from operable NSCLC based on published experience. We describe a patient with a solitary metachronous adrenal metastasis diagnosed 3 years after resection of NSCLC. Adrenalectomy was done, followed by combination chemotherapy with paclitaxel and carboplatin. MEDLINE literature on similar cases was reviewed and updated. Only 18 cases have been reported from 1965 to 2000. The median interval between the diagnosis of NSCLC and development of adrenal metastasis was 11.5 months. All patients were male. Unilateral adrenal metastases were reported in 15 patients, whereas 3 had bilateral metastases. Five patients were treated with adrenalectomy, and eight patients were treated with adrenalectomy and postoperative adjunctive chemotherapy. Chemotherapy alone was used in two patients and two patients underwent palliative radiation therapy. One patient was treated with intraarterial chemotherapy followed by radiation therapy. Solitary metachronous adrenal metastases are rare. There are no standard treatment guidelines for this group of patients. Review of the literature showed that median survival after treatment was 19 months for the group treated with adrenalectomy followed by chemotherapy; 15 months for the chemotherapy group; 14 months for the adrenalectomy group; and 8 months for the group treated with palliative radiation.

Map & Directions

2101 Elm St N Vamc Fargo, ND 58102
View Directions In Google Maps

Nearby Doctors

120 Broadway N
Fargo, ND 58102
701 370-0770
801 Broadway N
Fargo, ND 58102
701 342-2731
2601 Broadway N
Fargo, ND 58102
701 342-2900
801 Broadway N
Fargo, ND 58102
701 346-6236
801 Broadway N
Fargo, ND 58102
701 342-2731
1919 Elm St N
Fargo, ND 58102
701 934-4113
801 Broadway N
Fargo, ND 58102
701 346-6552
801 Broadway N
Fargo, ND 58102
701 344-4811